Sign In
Buy NVAX
$10.19
-0.0100 (-0.0980%)
At Close: Jun 04, 2026
Institutional investors are betting on Novavax. How attractive is the stock?
03:57pm, Wednesday, 12'th Oct 2022
Large holdings of stocks by institutional investors signal potential big price moves. That's because large investors can infuse the necessary liquidity to fuel huge market volatility.
Why Is Novavax (NVAX) Stock in the Spotlight Today?
10:14am, Wednesday, 12'th Oct 2022
Source: cortex-film / Shutterstock.com Novavax (NASDAQ: NVAX ) stock is on the move Wednesday following positive data from its Phase 3 PREVENT-19 trial and Study 307. Both of these cover the use of th
5 Investors Betting Big on Novavax (NVAX) Stock
04:53pm, Tuesday, 11'th Oct 2022
Source: Ascannio/Shutterstock.com Novavax (NASDAQ: NVAX ) stock closed higher by 6.7% today. Currently, the company is slated to share positive data from Phase 1 and 2 trials concerning its Covid-19-I
Novavax (NVAX) Stock Pops 8% With Vaccine Talks Underway
02:57pm, Tuesday, 11'th Oct 2022
Source: vovidzha / Shutterstock.com Today's incredible price action with vaccine maker Novavax (NASDAQ: NVAX ) has started to gain significant attention. At one point today, NVAX stock surged more t
Novavax's (NVAX) COVID-19 Booster Recommended in Switzerland
01:32pm, Tuesday, 11'th Oct 2022
The Federal Office of Public Health in Switzerland recommends Novavax's (NVAX) COVID-19 vaccine, Nuvaxovid, as a booster for both heterologous and homologous use in adults aged 18 years and older.
Dear NVAX Stock Fans, Mark Your Calendars for Oct. 11
04:32pm, Monday, 10'th Oct 2022
Shares of Novavax (NASDAQ: NVAX ) are in focus, as the biotechnology company will share data from its Covid-19-Influenza Combination (CIC) vaccine candidate for Phase 1 and 2 trials at the World Vacci
Novavax Is No Longer Expected To Become Profitable This Year — Is It A Sell?
01:35pm, Tuesday, 04'th Oct 2022
Is Novavax stock a sell after its second-quarter disappointment led to a guidance cut? NVAX stock ranks low among biotechs.
Why Novavax's (NVAX) COVID Vaccine Struggles for Market Share?
11:17am, Tuesday, 04'th Oct 2022
Despite being the first protein-based COVID-19 vaccine in many markets, Novavax's (NVAX) delayed product launch severely affected the company's prospects.
Here is What to Know Beyond Why Novavax, Inc. (NVAX) is a Trending Stock
10:32am, Tuesday, 04'th Oct 2022
Novavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Novavax: Beware This Hypercoaster
01:23am, Friday, 30'th Sep 2022
Novavax is the hypercoaster of stocks having crested $300 in 02/2022, falling to
These 2 Growth Stocks Have Fallen Out of Grace. Are They Buys?
09:45am, Thursday, 29'th Sep 2022
These vaccine makers have lost much of the momentum they built earlier in the pandemic.
Why Novavax Is Bouncing Back Today
01:22pm, Tuesday, 27'th Sep 2022
1 million doses of the company's COVID-19 vaccine are now available in the U.K.
Novavax Is No Longer Expected To Become Profitable This Year — Is It A Sell?
11:44am, Tuesday, 27'th Sep 2022
Is Novavax stock a sell after its second-quarter disappointment led to a guidance cut? NVAX stock ranks low among biotechs.
Novavax Stock Is Rebounding After Covid-19 Vaccines Launch in U.K.
09:11am, Tuesday, 27'th Sep 2022
An initial one million doses of the Novavax's Covid-19 vaccine are now available for use in the U.K.
Novavax stock up 4.4% premarket after it says 1 million COVID vaccine doses now available in the U.K.
08:37am, Tuesday, 27'th Sep 2022
Novavax Inc. NVAX, -10.14% said Tuesday that one million doses of its protein-based COVID vaccine Nuvaxovid are now available in the U.K. "With U.K. data showing that people infected with both COVID-1
